Pfizer reaches agreement with YaoPharma for an anti-obesity pill
Pfizer CEO Albert Bourla speaks during a press conference with European Commission President Ursula von der Leyen after a visit…
pharmaceutical products
Eli Lilly to build $6 billion manufacturing plant in Alabama
Eli Lilly CEO David A. Ricks speaks at a news conference at Generation Park in Houston, Monday, Sept. 23, 2025.…
FDA approves Merck drug for decimated cattle herds to stop screwworm
Cattle detained in the pens of the Unión Ganadera Regional de Chihuahua, at the Jerónimo-Santa Teresa border crossing in Ciudad…
RFK Jr. Vaccine Panel Postpones Vote on Infant Hepatitis B Vaccine
Health and Human Services Secretary Robert F. Kennedy Jr.'s hand-picked vaccine committee on Thursday postponed crucial votes on hepatitis B…
Access to abortion pill mifepristone holds steady under Trump, FDA review looms
Mifepristone and misoprostol pills are shown on Wednesday, Oct. 3, 2018, in Skokie, Illinois. Erin Hooley | Chicago Tribune |…
Novo Nordisk shares fall after Alzheimer's drug trial falls short of target
A view shows a Novo Nordisk sign in front of its office in Bagsvaerd, outside Copenhagen, Denmark, July 14, 2025.…
Eli Lilly reaches $1 trillion market value, first for a healthcare company
A sign with the company's logo sits outside Eli Lilly's headquarters in Indianapolis, Indiana, on March 17, 2024. Scott Olson…
Omada Health will begin prescribing GLP-1 and other obesity medications
The Omada Health logo is displayed on the screen of a smartphone. soup images | Light rocket | fake images…
Trump reaches agreement with Eli Lilly and Novo Nordisk
Wegovy injection pens laid out in Waterbury, Vermont, USA, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | fake…
Trump negotiates with Lilly and Novo Nordisk could expand access to anti-obesity drugs
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on November…